Company / AR per Share
Corcept Therapeutics Incorporated AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.57
FY2025
5-year range
$0.24 / $0.57
FY2021-FY2025
Trend
+9.0%
vs FY2024
Sector context
#62 of 115
Health Care
What the data says
At $0.57, Corcept Therapeutics Incorporated's ar per share ranks #62 of 115 in the Health Care sector. AR per Share has increased for 9 consecutive years, from $0.09 in FY2016 to $0.57 in FY2025.
Based on SEC 10-K filings.
0.57 in FY2025 with a 5-year CAGR of +20.0%.
Improved from $0.38 to $0.57 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +24.7%
- 5-Year CAGR
- +20.0%
- 10-Year CAGR
- -
Sector benchmark
#62 of 115 in Health CareTop 54% of 115This company $0.57 Sector average $27.05
▼
-97.9% below sector average
Key checks
Key Insights
- Corcept Therapeutics Incorporated's ar per share has grown for 9 consecutive years.
- In FY2025, ar per share increased 9.0% year-over-year.
- Ranks #62 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.57 | +9.0% |
| FY2024 | $0.52 | +36.9% |
| FY2023 | $0.38 | +30.1% |
| FY2022 | $0.29 | +23.9% |
| FY2021 | $0.24 | +3.5% |
| FY2020 | $0.23 | +32.0% |
| FY2019 | $0.17 | +13.0% |
| FY2018 | $0.15 | +12.9% |
| FY2017 | $0.14 | +50.9% |
| FY2016 | $0.09 | +46.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026